跳至主要内容
临床试验/CTRI/2021/05/033863
CTRI/2021/05/033863尚未招募未知

A Pre-clinical and Clinical Study to evaluate the efficacy ofAshwagandhadi Avaleha as an Adjuvant in the management ofTuberculosis with Anti Tubercular Treatment.

Principal0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
Principal

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Freshly diagnosed cases of tuberculosis(Pulmonary Tuberculosis and Tubercular pleural
  • 2. Patients of either sex between the age of 15-70 years.
  • 3. Patients willing and able to participate for 8 weeks duration

排除标准

  • 1. MDR and XDR cases of tuberculosis.
  • 2. Patients having diabetes mellitus.
  • 3. Patient with uncontrolled hypertension.
  • 4. Suffering from any other chronic infections including HIV.
  • 5. Patients Below the age of 15yrs and above the age of 70yrs.
  • 6. Patients not willing for trial.
  • 7. Individuals who have completed participation in any other clinical trial during the past three
  • 8. Any other condition which the Principal investigator thinks may jeopardize the study.

研究者

发起方
Principal

相似试验